Breakthrough in cancer therapies: directing the immune system to eliminate tumor cells.

Biotechnology

Education

Affimed

Affimed's headquarters in Heidelberg, Germany

Andreas Harstrick

Jens Pahl

Angus W. Smith

Susanne Spieler

Annette Kuehner

Séverine Sarlang

Michael Tesar

Ute Schniegler-Mattox

Ecaterina Altemüller

Joseph Costin

Holger J. Dulat

Andreas Premstaller

Christa Raab

Daniel Schütz

Eva-Bettina Böttger-Kaul

Dr. Angela Sickmann

Christopher Bruker

Michael Emig

Susanne Wingert

Sina Stäble

Dr. Jeanine H.

Anna-Lisa Höß

Stephane CHIRON

Kyrillos Sarigiannidis

Annalisa Jenkins

Mathieu Simon

Bernhard Ehmer

Stephen M. Ansell

Uta Kemmerich-Keil

Ulrike Köhl

Todd A. Fehniger

Sandro Matosevic

Thomas Hecht

The Leadership Team at Affimed is responsible for guiding the strategic direction of the company in the development and commercialization of innovative cancer therapies. Comprising key executives from diverse areas such as medical, scientific, financial, and operational expertise, this team collaborates to drive research initiatives, ensure regulatory compliance, foster business development, and enhance operational efficiency, all while prioritizing the mission of harnessing the immune system to combat cancer.

Leadership Team

The Clinical Development Team at Affimed is responsible for designing and executing clinical trials to evaluate the safety and efficacy of innovative cancer therapies. This team collaborates closely with medical, operational, and regulatory professionals to ensure seamless trial management and compliance, ultimately advancing groundbreaking treatments that harness the immune system to target and eliminate tumor cells.

Clinical Development Team

Affimed

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development Team

Offices

Affimed

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development Team

Offices

Related companies